These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 34919648)

  • 1. Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability.
    Carotenuto A; Cacciaguerra L; Pagani E; Preziosa P; Filippi M; Rocca MA
    Brain; 2022 Aug; 145(8):2785-2795. PubMed ID: 34919648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glymphatic system as a potential biomarker and therapeutic target in secondary progressive multiple sclerosis.
    Tomizawa Y; Hagiwara A; Hoshino Y; Nakaya M; Kamagata K; Cossu D; Yokoyama K; Aoki S; Hattori N
    Mult Scler Relat Disord; 2024 Mar; 83():105437. PubMed ID: 38244527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis.
    Margoni M; Pagani E; Meani A; Preziosa P; Mistri D; Gueye M; Moiola L; Filippi M; Rocca MA
    Ann Neurol; 2024 Jun; 95(6):1080-1092. PubMed ID: 38481063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
    Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging findings related to glymphatic system alterations in older adults with metabolic syndrome.
    Andica C; Kamagata K; Takabayashi K; Kikuta J; Kaga H; Someya Y; Tamura Y; Kawamori R; Watada H; Taoka T; Naganawa S; Aoki S
    Neurobiol Dis; 2023 Feb; 177():105990. PubMed ID: 36621631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment.
    Xie Y; Zhu H; Yao Y; Liu C; Wu S; Zhang Y; Zhu W
    Mult Scler Relat Disord; 2024 May; 85():105550. PubMed ID: 38493535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
    Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology.
    De Meo E; Storelli L; Moiola L; Ghezzi A; Veggiotti P; Filippi M; Rocca MA
    Brain; 2021 Feb; 144(1):186-197. PubMed ID: 33221873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
    Paling D; Solanky BS; Riemer F; Tozer DJ; Wheeler-Kingshott CA; Kapoor R; Golay X; Miller DH
    Brain; 2013 Jul; 136(Pt 7):2305-17. PubMed ID: 23801742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function.
    Zhang X; Wang Y; Jiao B; Wang Z; Shi J; Zhang Y; Bai X; Li Z; Li S; Bai R; Sui B
    Eur Radiol; 2024 Feb; 34(2):1314-1323. PubMed ID: 37610441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging.
    Rahmanzadeh R; Lu PJ; Barakovic M; Weigel M; Maggi P; Nguyen TD; Schiavi S; Daducci A; La Rosa F; Schaedelin S; Absinta M; Reich DS; Sati P; Wang Y; Bach Cuadra M; Radue EW; Kuhle J; Kappos L; Granziera C
    Brain; 2021 Jul; 144(6):1684-1696. PubMed ID: 33693571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
    Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
    Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study.
    Margoni M; Pagani E; Meani A; Storelli L; Mesaros S; Drulovic J; Barkhof F; Vrenken H; Strijbis E; Gallo A; Bisecco A; Pareto D; Sastre-Garriga J; Ciccarelli O; Yiannakas M; Palace J; Preziosa P; Rocca MA; Filippi M;
    J Neurol Neurosurg Psychiatry; 2022 Jul; 93(7):741-752. PubMed ID: 35580993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.